↓ Skip to main content

Adverse events with risankizumab in the real world: postmarketing pharmacovigilance assessment of the FDA adverse event reporting system

Overview of attention for article published in Frontiers in immunology, May 2023
Altmetric Badge

Mentioned by

twitter
2 X users

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
30 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Adverse events with risankizumab in the real world: postmarketing pharmacovigilance assessment of the FDA adverse event reporting system
Published in
Frontiers in immunology, May 2023
DOI 10.3389/fimmu.2023.1169735
Pubmed ID
Authors

Yamin Shu, Jing Chen, Yiling Ding, Qilin Zhang

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 30 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 30 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 6 20%
Student > Bachelor 4 13%
Professor 2 7%
Student > Master 2 7%
Researcher 2 7%
Other 5 17%
Unknown 9 30%
Readers by discipline Count As %
Medicine and Dentistry 7 23%
Unspecified 6 20%
Nursing and Health Professions 4 13%
Agricultural and Biological Sciences 1 3%
Neuroscience 1 3%
Other 1 3%
Unknown 10 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 May 2023.
All research outputs
#21,321,749
of 26,173,059 outputs
Outputs from Frontiers in immunology
#25,511
of 32,855 outputs
Outputs of similar age
#299,969
of 401,941 outputs
Outputs of similar age from Frontiers in immunology
#1,020
of 1,311 outputs
Altmetric has tracked 26,173,059 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 32,855 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.6. This one is in the 13th percentile – i.e., 13% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 401,941 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 14th percentile – i.e., 14% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,311 others from the same source and published within six weeks on either side of this one. This one is in the 11th percentile – i.e., 11% of its contemporaries scored the same or lower than it.